Eva Rodriguez-Marquez

Eva Rodriguez-Marquez

Auto-generated profile, based on publicly available information

Eva Rodriguez-Marquez

Department of Medical and Translational Biology

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in ACS Pharmacology & Translational Science
Verified
Journal Article
Open access
EREva Rodriguez-Marquez
Eva Rodriguez-Marquez
HNHanna Nord
Hanna Nord
DSDarío Puchán Sánchez
Darío Puchán Sánchez
AKAhmad Kassem
Ahmad Kassem
JCJosé María Andrés Castán
José María Andrés Castán
JHJonas von Hofsten
Jonas von Hofsten
Rhabdomyosarcoma is a highly aggressive soft tissue cancer that predominantly affects children and adolescents. Current treatment outcomes are poor, highlighting the urgent need for potent therapeutic alternatives. Preclinical research on photodynamic therapy (PDT) continues to gain attention as a promising and minimally invasive treatment strategy. Recently, PDT using the heavy-atom-free photosensitizer dibenzothioxanthene imide (DBI), which targets cancer-associated G-quadruplex (G4) DNA, has demonstrated high efficacy at nanomolar concentrations. In here, transgenic zebrafish with rhabdomyosarcoma tumors were utilized to evaluate the therapeutic potential of DBI treatment. We demonstrate that photoactivated DBI efficiently induce localized tumor necrosis, resulting in significant rhabdomyosarcoma regression compared to untreated controls. In fact, in comparison to the healthy cells surrounding the tumor, a high level of G4s was detected, as visualized by a G4-specific antibody. Notably, muscle and nerve cells within the treated tumor area were particularly affected, further underscoring its potency. These findings position DBI as a promising candidate for PDT in the treatment of rhabdomyosarcoma, offering selective G4-targeting capabilities and delivering robust therapeutic outcomes in in vivo models.